DR.Chip Biotechnology Incorporation reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 11.51 million compared to TWD 19.28 million a year ago. Revenue was TWD 11.51 million compared to TWD 19.28 million a year ago. Net loss was TWD 9.94 million compared to TWD 3.66 million a year ago. Basic loss per share was TWD 0.52 compared to TWD 0.08 a year ago. Diluted loss per share was TWD 0.52 compared to TWD 0.08 a year ago.
For the six months, sales was TWD 40.33 million compared to TWD 44.27 million a year ago. Revenue was TWD 40.33 million compared to TWD 44.27 million a year ago. Net loss was TWD 13.88 million compared to TWD 6.19 million a year ago. Basic loss per share was TWD 0.73 compared to TWD 0.13 a year ago. Diluted loss per share was TWD 0.73 compared to TWD 0.13 a year ago.